Raymond James & Associates’s Soligenix SNGX Stock Holding History

Raymond James & Associates’s Portfolio SNGX Stock Details SNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-82	Closed	-$42K	–	3687
2020 Q2	$42K	Hold	82	–	–	﹤0.01%	3395
2020 Q1	$33K	Hold	82	–	–	﹤0.01%	3358
2019 Q4	$29K	Hold	82	–	–	﹤0.01%	3592
2019 Q3	$19K	Buy	82 +21	+34%	+$5.19K	﹤0.01%	3540
2019 Q2	$10K	Hold	61	–	–	﹤0.01%	3586
2019 Q1	$13K	Hold	61	–	–	﹤0.01%	3556
2018 Q4	$13K	Hold	61	–	–	﹤0.01%	3463
2018 Q3	$28K	Hold	61	–	–	﹤0.01%	3527
2018 Q2	$14K	Hold	61	–	–	﹤0.01%	3513
2018 Q1	$29K	Hold	61	–	–	﹤0.01%	3361
2017 Q4	$33K	Hold	61	–	–	﹤0.01%	3316
2017 Q3	$33K	Hold	61	–	–	﹤0.01%	3272
2017 Q2	$30K	Sell	61 -1	-2%	-$615	﹤0.01%	3222
2017 Q1	$40K	Hold	62	–	–	﹤0.01%	3159
2016 Q4	$34K	Buy	+62	New	+$36K	﹤0.01%	3119

Other funds holding SNGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

PMFA

Plante Moran Financial Advisors Southfield, Michigan $2.15B AUM 22.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James & Associates's SNGX Position: Q3 2020 in Review

Raymond James & Associates sold out of Soligenix (SNGX) in Q3 2020, closing a stake of 82 shares — an estimated $42K sold.

Raymond James & Associates first reported a position in SNGX in Q4 2016 and held it in 15 quarters. The position peaked at $42K in Q2 2020. 27 funds tracked by Wall St. Rank hold SNGX as of Q3 2020.

Raymond James & Associates reported no remaining Soligenix position as of Q3 2020 after selling out during the quarter.
Raymond James & Associates sold 82 Soligenix shares in Q3 2020, an estimated $42K.
Raymond James & Associates first reported a position in Soligenix in Q4 2016 and held it in 15 quarters.
Raymond James & Associates's Soligenix position peaked at $42K in Q2 2020.
27 funds tracked by Wall St. Rank held Soligenix as of Q3 2020.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.